Phenotypic and functional analysis of human fetal liver hematopoietic stem cells in culture

Stem Cells and Development

Volumn 16, Issue 2, 2007, Pages 281-295

  Rollini, Pierre ^a,b   Hull, Eveline Faes Van't ^a   Kaiser, Stefan ^c   Kapp, Ursula ^c   Leyvraz, Serge ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CD34 SELECTION; CELL COUNT; CELL POPULATION; CELL REGENERATION; CELL SUSPENSION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FETUS; FETUS LIVER; FUNCTIONAL ASSESSMENT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PHENOTYPE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ADULT; ANIMALS; ANTIGENS, CD34; CELL LINEAGE; CELL TRANSPLANTATION; CELLS, CULTURED; FETUS; HEMATOPOIETIC STEM CELLS; HUMANS; LIVER; MICE; MICE, INBRED NOD; MICE, SCID; PHENOTYPE;

MUS;

EID: 34249010232     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.0096     Document Type: Article

References (77)

1. Domen J and IL Weissman. (1999). Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate. Mol Med Today 5:201-208.
2. Verfaillie CM. (2002). Hematopoietic stem cells for transplantation. Nature Immunol 3:314-317.
3. Shizuru JA, RS Negrin and IL Weissman. (2005). Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med 56:509-538.
4. Durand C and E Dzierzak. (2005). Embryonic beginnings of adult hematopoietic stem cells. Haematologica 90:100-108.
5. Tavassoli M. (1991). Embryonic and fetal hemopoiesis: an overview. Blood Cells 17:269-281.
6. Lansdorp PM, W Dragowska and H Mayani. (1993). Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178:787-791.
7. Rebel VI, CL Miller, CJ Eaves and PM Lansdorp. (1996), The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their adult bone marrow counterparts. Blood 87:3500-3507.
8. Huang S, P Law, D Young and AD Ho. (1998). Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood. Exp Hematol 26:1162-1171.
9. ++ cells for transplantation. Bone Marrow Transplant 24:451-461.
10. Holyoake TL, FE Nicolini and CJ Eaves. (1999). Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 27:1418-1427.
11. Nicolini FE, TL Holyoake, JD Cashman, PP Chu, K Lambie and CJ Eaves. (1999). Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice. Blood 94:2686-2695.
12. Lucarelli G, T Izzi, A Porcellini, C Delfini, M Galimberti, L Moretti, P Polchi, F Agostinelli, M Andreani, M Manna and B Dallapiccola. (1982). Fetal liver transplantation in 2 patients with acute leukaemia after total body irradiation. Scand J Haematol 28:65-71.
13. Touraine JL. (1983). Bone-marrow and fetal-liver transplantation in immunodeficiencies and inborn errors of metabolism: lack of significant restriction of T-cell function in long-term chimeras despite HLA-mismatch. Immunol Rev 71:103-121.
14. Gale RP. (1987). Fetal liver transplantation in aplastic anemia and leukemia. Thymus 10:89-94.
15. Mehra NK, V Taneja, B Jhinghon, T Chaudhuri, S Sharma and V Kochupillai. (1987). HLA status following fetal liver transplantation in aplastic anaemia and acute myeloid leukaemia. Thymus 10:131-136.
16. Touraine JL, MG Roncarolo, R Bacchetta, D Raudrant, A Rebaud, S Laplace, P Cesbron, L Gebuhrer, MT Zabot, F Touraine et al. (1993). Fetal liver transplantation: biology and clinical results. Bone Marrow Transplant 11:119-122.
17. Mehta J, R Powles, J Trcleaven, S Kulkarni, C Horton and S Singhal. (1997). Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: an important modifiable factor influencing outcome. Blood 90:3808-3810.
18. Pecora AL. (2001). Progress in clinical application of use of progenitor cells expanded with hematopoietic growth factors. Curr Opin Hematol 8:142-148.
19. Bittencourt H, V Rocha, S Chevret, G Socie, H Esperou, A Devergie, L Dal Cortivo, JP Marolleau, F Garnier, P Ribaud and E Gluckman. (2002). Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood 99:2726-2733.
20. Wang JC, M Doedens and JE Dick. (1997). Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 89:3919-3924.
21. Devine SM, HM Lazarus and SG Emerson. (2003). Clinical application of hematopoietic progenitor cell expansion: current status and future prospects. Bone Marrow Transplant 31:241-252.
22. Flake AW and ED Zanjani. (1999). In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood 94:2179-2191.
23. Westgren M, O Ringden, P Bartmann, TH Bui, B Lindton, J Mattsson, M Uzunel, H Zetterquist and M Hansmann. (2002). Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency. Am J Obstet Gynecol 187:475-482.
24. Grewal SS, JN Barker, SM Davies and JE Wagner. (2003). Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 101:4233-4244.
25. Rocha V, G Sanz and E Gluckman. (2004). Umbilical cord blood transplantation. Curr Opin Hematol 11:375-385.
26. Krause DS, MJ Fackler, CI Civin and WS May. (1996). CD34: structure, biology, and clinical utility. Blood 87: 1-13.
27. + cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 88: 3223-3229.
28. + peripheral blood stem cells for an autologous transplant? Stem Cells Dev 13:598-606.
29. - progenitor cells. Blood 77:1218-1227.
30. +/ 38lo human marrow cells after in vitro cytokine exposure. Blood 85:1480-1487.
31. + human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source. Exp Hematol 26:1034-1042.
32. Bhatia M, JC Wang, U Kapp, D Bonnet and JE Dick. (1997). Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 94:5320-5325.
33. + side population (SP) phenotype. J Clin Invest 108:1071-1077.
34. -. Leukemia 17:960-964.
35. - low/negative hematopoietic stem cell. Science 273:242-245.
36. Goodell MA, M Rosenzweig, H Kim, DF Marks, M DeMaria, G Paradis, SA Grupp, CA Sieff, RC Mulligan and RP Johnson. (1997). Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Med 3:1337-1345.
37. Bhatia M, D Bonnet, B Murdoch, OI Gan and JE Dick. (1998). A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nature Med 4: 1038-1045.
38. + cells. Exp Hematol 26: 353-360.
39. Sato T, JH Laver and M Ogawa. (1999). Reversible expression of CD34 by murine hematopoietic stem cells [see comments]. Blood 94:2548-2554.
40. Matsuoka S, Y Ebihara, M Xu, T Ishii, D Sugiyama, H Yoshino, T Ueda, A Manabe, R Tanaka, Y Ikeda, T Nakahata and K Tsuji. (2001). CD34 expression on long-term repopulating hematopoietic stem cells changes during developmental stages. Blood 97:419-425.
41. Ogawa M, F Tajima, T Ito, T Sato, JH Laver and T Deguchi. (2001). CD34 expression by murine hematopoietic stem cells. Developmental changes and kinetic alterations. Ann NY Acad Sci 938:139-145.
42. + or CD34. Leuk Lymphoma 40:221-234.
43. - cell preparations. Exp Hematol 29:910-921.
44. +)Lin(-) and CD34(-)Lin(-) cells reveals functional interaction between repopulating hematopoietic stem cells. Leukemia 17:1613-1625.
45. Wognum AW, AC Eaves and TE Thomas. (2003). Identification and isolation of hematopoietic stem cells. Arch Med Res 34:461-475.
46. Goodell MA, K Brose, G Paradis, AS Conner and RC Mulligan. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183:1797-1806.
47. Zhou S, JD Schuetz, KD Bunting, AM Colapietro, J Sampath, JJ Morris, I Lagutina, GC Grosveld, M Osawa, H Nakauchi and BP Sorrentino. (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Med 7:1028-1034.
48. Larochelle A, J Vormoor, H Hanenberg, JC Wang, M Bhatia, T Lapidot, T Moritz, B Murdoch, XL Xiao, I Kato, DA Williams and JE Dick. (1996). Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nature Med 2:1329-1337.
49. Ballen KK, H Valinski, D Greiner, LD Shultz, PS Becker, CC Hsieh, FM Stewart and PJ Quesenberry. (2001). Variables to predict engraftment of umbilical cord blood into immunodeficient mice: usefulness of the non-obese diabetic - severe combined immunodeficient assay. Br J Haematol 114:211-218.
50. Kyba M and GQ Daley. (2003). Hematopoiesis from embryonic stem cells: lessons from and for ontogeny. Exp Hematol 31:994-1006.
51. Dorrell C, OI Gan, DS Pereira, RG Hawley and JE Dick. (2000). Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood 95:102-110.
52. Danet GH, HW Lee, JL Luongo, MC Simon and DA Bonnet. (2001). Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion. Exp Hematol 29:1465-1473.
53. Donaldson C, P Denning-Kendall, B Bradley and J Hows. (2001). The CD34(+)CD38(neg) population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function. Bone Marrow Transplant 27:365-371.
54. Peters R, S Leyvraz, E Faes-Van't Hull, P Jaunin, S Gerber and P Rollini. (2002). Long-term ex vivo expansion of human fetal liver primitive haematopoietic progenitor cells in stroma-free cultures. Br J Haematol 119:792-802.
55. Rollini P, S Kaiser, E Faes-van't Hull. U Kapp and S Leyvraz. (2004). Long-term expansion of transplantable human fetal liver hematopoietic stem cells. Blood 103: 1166-1170.
56. Zwicky C, S Gerber, D Gasparini, F Forestier, P Hohlfeld, JD Tissot and P Schneider. (2000). Preparation and analysis of fetal liver extracts. Bone Marrow Transplant 26:667-671.
57. Peters R, S Leyvraz and L Perey. (1998). Apoptotic regulation in primitive hematopoietic precursors. Blood 92: 2041-2052.
58. Perey L, R Peters, S Pampallona, P Schneider, N Gross and S Leyvraz. (1998). Extensive phenotypic analysis of CD34 subsets in successive collections of mobilized peripheral blood progenitors. Br J Haematol 103:618-629.
59. Wagers AJ, RI Sherwood, JL Christensen and IL Weissman. (2002). Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297:2256-2259.
60. Camargo FD, R Green, Y Capetenaki, KA Jackson and MA Goodell. (2003). Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med 9:1520-1527.
61. Guenechea G, OI Gan, C Dorrell and JE Dick. (2001). Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nature Immunol 2:75-82.
62. + cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci USA 99:413-418.
63. Mazurier F, M Doedens, OI Gan and JE Dick. (2003). Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nature Med 9:959-963.
64. Horn PA, BM Thomasson, BL Wood, RG Andrews, JC Morris and HP Kiem. (2003). Distinct hematopoietic stem/ progenitor cell populations are responsible for repopulating NOD/SCID mice compared with nonhuman primates. Blood 102:4329-4335.
65. Arai F, A Hirao, M Ohmura, H Sato, S Matsuoka, K Takubo, K Ito, GY Koh and T Suda. (2004). Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118:149-161.
66. Zhang CC and HF Lodish. (2005). Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion. Blood 105:4314-4320.
67. Piacibello W, F Sanavio, L Garetto, A Severino, D Bergandi, J Fenario, F Fagioli, M Berger and M Aglietta, (1997). Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89:2644-2653.
68. Gammaitoni L, S Bruno, F Sanavio, M Gunetti, O Kollet, G Cavalloni, M Falda, F Fagioli, T Lapidot, M Aglietta and W Piacibello. (2003). Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Exp Hematol 31:261-270.
69. - cells assured by intra-bone marrow injection. Blood 101:2924-2931.
70. Yahata T, K Ando, T Sato, H Miyatake, Y Nakamura, Y Muguruma, S Kato and T Hotta. (2003). A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 101:2905-2913.
71. Hsu HC, H Ema, M Osawa, Y Nakamura, T Suda and H Nakauchi. (2000). Hematopoietic stem cells express Tie-2 receptor in the murine fetal liver. Blood 96:3757-3762.
72. +) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 93:3736-3749.
73. +) hematopoietic stem cells. Exp Hematol 28:1297-1305.
74. Gupta P, TR Oegema, Jr., JJ Brazil, AZ Dudek, A Slungaard and CM Verfaillie. (2000). Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood 95:147-155.
75. Lazzari L, S Lucchi, P Rebulla, L Porretti, G Piglisi, L Lecchi and G Sirchia. (2001). Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system. Br J Haematol 112:397-404.
76. Glimm H and CJ Eaves. (1999). Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood 94:2161-2168.
77. Quesenberry PJ, GA Colvin and JF Lambert. (2002). The chiaroscuro stem cell: a unified stem cell theory. Blood 100:4266-4271.